Literature DB >> 18668202

Pleiotropic effects of sphingolipids in skeletal muscle.

P Bruni1, C Donati.   

Abstract

Studies of the last two decades have demonstrated that sphingolipids are important signalling molecules exerting key roles in the control of fundamental biological processes including proliferation, differentiation, motility and survival. Here we review the role of bioactive sphingolipids such as ceramide, sphingosine, sphingosine 1-phosphate, ganglioside GM3, in the regulation of skeletal muscle biology. The emerging picture is in favour of a complex role of these molecules, which appear implicated in the activation of muscle resident stem cells, their proliferation and differentiation, finalized at skeletal muscle regeneration. Moreover, they are involved in the regulation of contractile properties, tissue responsiveness to insulin and muscle fiber trophism. Hopefully, this article will provide a framework for future investigation into the field, aimed at establishing whether altered sphingolipid metabolism is implicated in the onset of skeletal muscle diseases and identifying new pharmacological targets for the therapy of multiple illnesses, including muscular dystrophies and diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668202     DOI: 10.1007/s00018-008-8236-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  28 in total

1.  Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Kwang-Mook Jung; Christopher Nguyen; Agnesa Avanesian; Tahseen Mozaffar; Daniele Piomelli; Virginia E Kimonis
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

Review 2.  Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.

Authors:  Mariana N Nikolova-Karakashian; Michael B Reid
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

3.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

4.  Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila.

Authors:  Mario Pantoja; Karin A Fischer; Nicholas Ieronimakis; Morayma Reyes; Hannele Ruohola-Baker
Journal:  Development       Date:  2012-11-15       Impact factor: 6.868

Review 5.  Lyase to live by: sphingosine phosphate lyase as a therapeutic target.

Authors:  Ashok Kumar; Julie D Saba
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

6.  Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor α in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity.

Authors:  Jessica S Ross; Wei Hu; Bess Rosen; Ashley J Snider; Lina M Obeid; L Ashley Cowart
Journal:  J Biol Chem       Date:  2013-06-13       Impact factor: 5.157

7.  Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.

Authors:  Wei Hu; Jacek Bielawski; Fahumiya Samad; Alfred H Merrill; L Ashley Cowart
Journal:  J Lipid Res       Date:  2009-04-15       Impact factor: 5.922

Review 8.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013

Review 9.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

10.  Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.

Authors:  Jessica S Ross; Sarah B Russo; Georgia C Chavis; Lauren A Cowart
Journal:  Clin Lipidol       Date:  2017-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.